Skip to Content
Merck

Skip To

A8036

N-Acetylheparin sodium salt

~90%

Sign In to View Organizational & Contract Pricing.

About This Item

UNSPSC Code:
12352201
NACRES:
NA.25
MDL number:


assay

~90%

Quality Level

form

solid

Application

N-Acetylheparin, derivitized porcine mucosal heparin without anticoagulant properties, may be used to protect cardiac, vascular and neural tissues by inhibiting complement activation and neutrophil infiltration of the damage site.

Preparation Note

Prepared from porcine mucosal heparin by a modification of the method of Nagasawa, K. and Inoue, Y., Methods Carb. Chem., 8, 291 (1980).

Compare Similar Items

View Full Comparison

Show Differences

1 of 1

This Item
772429A690428007
assay

~90%

assay

90%

assay

90-95%

assay

~90% (HPLC)

Quality Level

200

Quality Level

100

Quality Level

200

Quality Level

100

form

solid

form

solid

form

solid

form

solid


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



J L Park et al.
Pharmacology, 58(3), 120-131 (1999-02-02)
The ability of the heparin derivative, N-acetylheparin (NHEP) to protect the heart from regional ischemia/reperfusion injury was examined in vivo. NHEP (2 mg/kg i.v.) or vehicle was administered 2 h before occlusion of the left circumflex coronary (LCX) artery. Open-chest
P C Kouretas et al.
Circulation, 99(8), 1062-1068 (1999-03-02)
Coronary endothelial dysfunction after brief ischemia-reperfusion (IR) remains a clinical problem. We investigated the role of heparin and N-acetylheparin, a nonanticoagulant heparin derivative, in modulating coronary endothelial function after IR injury, with an emphasis on defining the role of the
P C Kouretas et al.
Journal of molecular and cellular cardiology, 30(12), 2669-2682 (1999-02-17)
Heparin, which is widely used clinically, has recently been shown to have specific properties affecting the vascular endothelium. We hypothesized that heparin stimulates endothelial nitric oxide synthase (eNOS) activity by a mechanism independent of its anticoagulant properties and dependent on



Global Trade Item Number

SKUGTIN
A8036-25MG04061833046876
A8036-10MG04061833046869

Questions

  1. How should item A8036 - N-Acetylheparin sodium salt be reconstituted?

    1 answer
    1. The concentration is 50 mg/mL in water.

      Helpful?

Reviews

No rating value

Active Filters